Correlation Between Merck and UBM Development

Can any of the company-specific risk be diversified away by investing in both Merck and UBM Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and UBM Development into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and UBM Development AG, you can compare the effects of market volatilities on Merck and UBM Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of UBM Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and UBM Development.

Diversification Opportunities for Merck and UBM Development

0.65

Correlation Coefficient

Merck  UBM Development

Poor diversification

The 3 months correlation between Merck and UBM is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and UBM Development AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UBM Development AG and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with UBM Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UBM Development AG has no effect on the direction of Merck i.e., Merck and UBM Development go up and down completely randomly.

Pair Corralation between Merck and UBM Development

Assuming the 90 days trading horizon Merck Company is expected to generate 0.76 times more return on investment than UBM Development. However, Merck Company is 1.32 times less risky than UBM Development. It trades about -0.08 of its potential returns per unit of risk. UBM Development AG is currently generating about -0.29 per unit of risk. If you would invest  10,303  in Merck Company on September 12, 2024 and sell it today you would lose (643.00) from holding Merck Company or give up 6.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.46%
Values	Daily Returns

Merck Company  vs.  UBM Development AG

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward-looking signals, Merck is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

UBM Development AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days UBM Development AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Merck and UBM Development

The main advantage of trading using opposite Merck and UBM Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, UBM Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UBM Development will offset losses from the drop in UBM Development's long position.

The idea behind Merck Company and UBM Development AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.